DrugPatentWatch Database Preview
Fospropofol disodium - Generic Drug Details
What are the generic sources for fospropofol disodium and what is the scope of fospropofol disodium freedom to operate?
Fospropofol disodium
is the generic ingredient in one branded drug marketed by Eisai Inc and is included in one NDA. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.Summary for fospropofol disodium
| US Patents: | 2 |
| Tradenames: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Bulk Api Vendors: | 17 |
| Clinical Trials: | 18 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for fospropofol disodium |
| DailyMed Link: | fospropofol disodium at DailyMed |
Synonyms for fospropofol disodium
| 258516-87-9 |
| 30868AY0IF |
| AC-25763 |
| AC1MI4YF |
| ACN-049983 |
| AKOS024406472 |
| AN-3709 |
| Aquavan |
| Aquavan (TN) |
| Aquavan injection |
| CHEMBL2021422 |
| D02EZM |
| D04257 |
| dipotassium 2,6-diisopropylphenoxymethyl phosphate |
| disodium (2,6-diisopropylphenoxy)methyl phosphate |
| disodium [2,6-di(propan-2-yl)phenoxy]methyl phosphate |
| DISODIUM 2,6-DIISOPROPYLPHENOXYMETHYL PHOSPHATE |
| DTXSID10180504 |
| FOSPROPOFOL DISODIUM (AQUAVAN) |
| Fospropofol disodium (USAN) |
| Fospropofol disodium salt |
| GPI 15715 |
| GPI-15715 |
| KB-52180 |
| LS-192060 |
| Lusedra |
| Lusedra (TN) |
| Methanol, (2,6-bis(1-methylethyl)phenoxy)-, dihydrogen phosphate, disodium salt |
| OR068284 |
| OR249427 |
| phosphoric acid 2,6-diisopropylphenoxymethyl monoester disodium salt |
| PQ-1002 |
| UNII-30868AY0IF |
US Patents and Regulatory Information for fospropofol disodium
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Eisai Inc | LUSEDRA | fospropofol disodium | SOLUTION;INTRAVENOUS | 022244-001 | Dec 12, 2008 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | Y | ➤ Sign Up | |||
| Eisai Inc | LUSEDRA | fospropofol disodium | SOLUTION;INTRAVENOUS | 022244-001 | Dec 12, 2008 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | Y | Y | ➤ Sign Up | ||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Expired US Patents for fospropofol disodium
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Eisai Inc | LUSEDRA | fospropofol disodium | SOLUTION;INTRAVENOUS | 022244-001 | Dec 12, 2008 | ➤ Sign Up | ➤ Sign Up |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
International Patents for fospropofol disodium
| Country | Document Number | Estimated Expiration |
|---|---|---|
| Spain | 2268876 | ➤ Sign Up |
| Hungary | 229401 | ➤ Sign Up |
| European Patent Office | 1683803 | ➤ Sign Up |
| Japan | 2002522443 | ➤ Sign Up |
| Country | Document Number | Estimated Expiration |
